Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A mouse renal tubule expressing the mTmG reporter, which was grown ex vivo from primary cell organoids using a new 3D culture system for modelling pathogenesis in autosomal dominantpolycystic kidney disease. Cover image provided by Eryn E. Dixon of the Woodward Laboratory in the Department of Physiology and the Baltimore PKD Research and Clinical Core Center at the University of Maryland School of Medicine, Baltimore, MD, USA.
Renal cell carcinoma (RCC) is the most common malignancy seen in the nephrology clinic, yet most nephrologists have inadequate knowledge of current treatment options. Here we discuss RCC presentation and therapies, including potential renal adverse effects, and highlight the need for involvement of nephrologists in the multidisciplinary management of this disease.
The cellular origins of angiomyolipoma and other tuberous sclerosis complex-associated neoplasms are unknown. Now, two studies show that these neoplasms derive from cancer stem cells that originate from multipotent renal epithelial cells. The new findings provide a link between stemness and tumorigenesis in the kidney.
Acute kidney injury is a heterogeneous clinical syndrome with multiple aetiologies, including sepsis, surgery, hypoperfusion and nephrotoxin exposure. Here, Kellum and Prowle discuss the different causes, phenotypes and pathogenic pathways of AKI and describe how consideration of such paradigms could be used to guide treatment.
Increasing evidence suggests that renin-expressing cells are involved in a range of physiological processes beyond their traditional role in blood pressure regulation. Here, the authors describe the role of these cells in nephrovascular development, regeneration, oxygen sensing, haematopoiesis and immune responses.
Monoclonal immunoglobulin deposition produces complex diseases with heterogeneous phenotypes, making it difficult to identify the underlying mechanisms of immunoglobulin aggregation and deposition. In this Review, the authors discuss animal models of various human immunoglobulin deposition diseases, and each model's drawbacks and contributions to our understanding of these diseases.
Some animals have developed mechanisms to protect them from environmental stresses, whereas others remain susceptible. Here, Stenvinkel et al. discuss how a better understanding of susceptibility and protective mechanisms could provide insights to novel strategies for the prevention and treatment of several human diseases, such as chronic kidney disease and ageing-associated complications.